E-CAIO

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2014-05-22 for E-CAIO manufactured by Ge Healthcare Finland Oy.

Event Text Entries

[16597571] This customer reports that the e-caio gas module provided inaccurately high fico2 and etco2 readings during a procedure. The patient was manually bagged with an ambu bag and medicated with propofol. No further consequences to the patient.
Patient Sequence No: 1, Text Type: D, B5


[16691094] Patient data not currently available. Email address of reporter unknown. Date of manufacture unknown at this time. A follow-up report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9610105-2014-00012
MDR Report Key3850600
Report Source05,06
Date Received2014-05-22
Date of Report2014-04-23
Date of Event2014-04-23
Date Mfgr Received2014-04-23
Date Added to Maude2014-06-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationBIOMEDICAL ENGINEER
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactDEB LAHR
Manufacturer Street540 W. NORTHWEST HWY.
Manufacturer CityBARRINGTON IL 60010
Manufacturer CountryUS
Manufacturer Postal60010
Manufacturer Phone8472774472
Manufacturer G1GE HEALTHCARE
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameE-CAIO
Generic NameANALYZER, GAS, OXYGEN, GASEOUS-PHASE
Product CodeCCL
Date Received2014-05-22
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerGE HEALTHCARE FINLAND OY
Manufacturer AddressHELSINKI FI


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2014-05-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.